The management of failed autologous chondrocyte implantation (ACI) and matrix-assisted autologous chondrocyte implantation (MACI) for the treatment of symptomatic osteochondral defects in the knee represents a major challenge. Patients are young, active and usually unsuitable for prosthetic replacement. This study reports the results in patients who underwent revision cartilage transplantation of their original ACI/MACI graft for clinical or graft-related failure. We assessed 22 patients (12 men and 10 women) with a mean age of 37.4 years (18 to 48) at a mean of 5.4 years (1.3 to 10.9). The mean period between primary and revision grafting was 46.1 months (7 to 89). The mean defect size was 446.6 mm² (150 to 875) and they were located on 11 medial and two lateral femoral condyles, eight patellae and one trochlea.

The mean modified Cincinnati knee score improved from 40.5 (16 to 77) pre-operatively to 64.9 (8 to 94) at their most recent review (p < 0.001). The visual analogue pain score improved from 6.1 (3 to 9) to 4.7 (0 to 10) (p = 0.042). A total of 14 patients (63%) reported an ‘excellent’ (n = 6) or ‘good’ (n = 8) clinical outcome, 5 ‘fair’ and one ‘poor’ outcome. Two patients underwent patellofemoral joint replacement. This study demonstrates that revision cartilage transplantation after primary ACI and MACI can yield acceptable functional results and continue to preserve the joint.

Cite this article: Bone Joint J 2014;96-B:54–8.

Total knee replacement in a commonly performed procedure in the United Kingdom with more than 76000 primary procedures performed in 2010. With so many procedures performed there has to be a robust way of assessing the outcome of the procedure. Gait analysis is a valuable tool in objectively assessing the these patients. Inertial movement units (IMU's) are a fairly new development in gait analysis. The aim of our project is to use IMUs to assess the differences in gait profile between a cohort of healthy controls, a group of pre operative knee replacement patients, a group of 8 week post operative patients and finally a group of post operative knee replacement patients at 1 year. We studied a total of 47 patients. We also had data from a previous study done on healthy controls using the same measurement tool. We measured three parameters: peak swing phase flexion, peak stance phase flexion and stride duration. Our findings indicate that pre-operative patients have a significantly reduced peak flexion in swing and stance with increased stride duration. This shows no improvement at the 8 week mark. At the 1 year mark peak flexion in swing returns to pre operative levels but flexion in stance and stride duration are still poor. These findings may not have been identified without gait analysis. Gait analysis using intertial movement units will add much information to radiographs and clinical examination. This information can also be used to tailor individual patients rehabilitation.

The Royal National Orthopaedic Hospital has completed an extensive trial of ACI versus MACI in the treatment of symptomatic osteochondral defects of the knee. A new technique has now been proposed which is quicker and easier to perform. This is the Gel-Type Autologous Chondrocyte Transplantation, CHONDRONTM. At Stanmore CHONDRON has been used for the past 17 months. Our aim was to assess the short term functional outcome of patients who have undergone CHONDRONTM using validated outcome scoring questionnaires. We retrospectively reviewed the notes of 43 patients that had undergone CHONDRONTM over one year ago and scored them using the Modified Cincinnati Score, the Visual Analogue Score and the Benltey Stanmore Functional Rating Score.